Form 4 for VCEL Vericel Corp
Accepted 2025-02-26 00:00:00 ET · period of report 2025-02-24 · accession 0001140361-25-006082 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-02-26 | 2025-02-24 | VCEL | Flynn Sean C. | CLO | M - OptEx | $0.00 | +3,000 | 3,756 | +397% | $0 |
| DT | 2025-02-26 | 2025-02-24 | VCEL | Flynn Sean C. | CLO | F - Tax | $52.33 | -1,331 | 2,425 | -35% | -$69.7K |
| DT | 2025-02-26 | 2025-02-25 | VCEL | Flynn Sean C. | CLO | S - Sale+OE | $52.07 | -1,669 | 756 | -69% | -$86.9K |
| DT | 2025-02-26 | 2025-02-24 | VCEL | Flynn Sean C. | CLO | M - OptEx | — | +3,000 | 9,000 | +50% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-24 | M | A | 3,000 | $0.00 | 3,756 | D | — | — | (F1) The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 22, 2024. The remaining RSUs will vest in annual installments on February 22, 2026, February 22, 2027, and February 22, 2028, respectively. (F2) These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| 2 | Common | Common Stock | 2025-02-24 | F | D | 1,331 | $52.33 | 2,425 | D | — | — | (F3) These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. (F2) These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| 3 | Common | Common Stock | 2025-02-25 | S | D | 1,669 | $52.07 | 756 | D | — | — | (F4) The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. (F2) These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| 4 | Derivative | Restricted Stock Unit | 2025-02-24 | M | A | 3,000 | — | 9,000 | D | — · — to — | 3,000 Common Stock | (F7) The Fair Market Value of the vested derivative securities is $52.33 per share. (F5) Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. (F1) The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 22, 2024. The remaining RSUs will vest in annual installments on February 22, 2026, February 22, 2027, and February 22, 2028, respectively. (F6) No expiration date for this type of award. |